A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Hemophilia A

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Center for Inherited Blood Disorders, Orange, California, United States
Kaiser Permanente, Vallejo, California, United States

Study leads

Clinical Trials
Study Director
Hoffmann-La Roche

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Hemophilia A

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sacramento, United States · Washington D.C., United States

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder

Abroad (travel likely)Recruiting

Phoenix, United States · Little Rock, United States

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

Hemophilia A

Abroad (travel likely)RecruitingPHASE3

Kashihara-shi, Japan · Shinjuku-Ku, Japan

Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain

Hemophilia · Chronic Pain

Abroad (travel likely)Recruiting

Santiago, Chile